Article

jdsupra.com on 2016-12-29 21:03

FDA Issues New Guidance on Use of Clinical Pharmacology Studies to Show Biosimilarity

The FDA issued a new Guidance today, titled “Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product.” The ...

Related news

Summary of FDA Clinical Pharmacology Guidance for Demonstrating Biosimilarity jdsupra.com
FDA issues guidance on use of EHR data in clinical research jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance on Use of Data Monitoring Committees in Clinical Trials jdsupra.com
FDA Issues Draft Guidance on Use of Electronic Informed Consent in Clinical Trials jdsupra.com
Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use jdsupra.com
FDA issues final guidance to improve diversity in clinical trials Fox News
FDA Issues Guidance on Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Final Clinical Decision Support Software Guidance jdsupra.com
Cures
FDA Issues Final Guidance on Informed Consent in Clinical Investigations jdsupra.com
Clinical Research: FDA Issues Draft Guidance on Informed Consent jdsupra.com
Cures
FDA Issues Long-Awaited Final Clinical Decision Support Software Guidance jdsupra.com
Cures
FDA Issues Guidance for Ongoing Clinical Trials During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA issues milestone draft guidance on decentralized clinical trial design & implementation jdsupra.com
Digital Health: FDA Issues Long-Awaited Draft Guidance on Clinical Decision Support Technology jdsupra.com
FDA Issues Guidance on Clinical Trials During the COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Final Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices jdsupra.com
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance jdsupra.com
FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors jdsupra.com
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors jdsupra.com